KCM
CASC

Kennedy Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Kennedy Capital Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-493,561
Closed -$1.83M – 796
2017
Q4 		$1.83M Buy
+493,561
New +$1.83M 0.03% 623